CEA and newcleo to Partner On Generation IV Reactors

CEA and newcleo to Partner On Generation IV Reactors CEA, the French Alternative Energies and Atomic Energy Commission (ENS Corporate Member) and newcleo, a European nuclear technology developer, signed a partnership agreement to jointly explore Generation IV reactor technologies. In particular, this collaboration focuses on the realisation of newcleo’s LFR project and covers areas like…

Krško

EIMV Cooperates In Monitoring Safe Operation of Krško NPP

EIMV Cooperates In Monitoring Safe Operation of Krško NPP This year, Elektroinstitut Milan Vidmar (EIMV, ENS Corporate Member) is the coordinator of the authorized organizations for radiation and nuclear safety for the preparation of the Consolidated Expert Assessment of maintenance works, interventions, and tests during the provisional shutdown and fuel replacement at the Krško nuclear…

Tractebel Pantera

Tractebel To Support PanTera’s Radioisotope Production Facility

Tractebel To Support PanTera’s Radioisotope Production Facility Tractebel (ENS Corporate Member), together with its partner MODULO architects, will support the design and construction of PanTera’s actinium-225 production facility in Belgium, enabling breakthrough cancer treatments. The PanTera facility will be built in Mol (Belgium) and is dedicated to the production of 225Ac via photonuclear activation on…

ENS President Stefano Monti

NucNet – Interview with ENS President Stefano Monti

ENS HSC Position Paper “Nuclear Scientific Community for Global Sustainable Development” This interview has been published on NucNet – The Independent Nuclear News Agency, on 20th March 2024. NucNet is a Brussels-based independent news agency and information network for the global nuclear industry. It operates a 24/7 service reporting nuclear-related news about the operation and…

nuclear medicine supply chain production

PSI Developed A New Promising Radiopharmaceutical Successfully Tested

PSI Developed A New Promising Radiopharmaceutical Successfully Tested A promising radiopharmaceutical against metastatic neuroendocrine tumours has been successfully tested for the first time in patients at the University Hospital Basel, Switzerland. The new radionuclide terbium-161 was developed at the Paul Scherrer Institute (PSI, ENS Corporate Member).  This isotope has the property that when the radioisotope…

Tractebel Teams Up With Thorizon On Molten Salt Reactors

Tractebel Teams Up With Thorizon On Molten Salt Reactors Tractebel (ENS Corporate Member) and the French-Dutch start-up Thorizon signed a three-year partnership to advance the Thorizon One molten salt reactor. By providing engineering services, including support on the conceptual design, computational modelling, cost estimates and design reviews, Tractebel will support Thorizon in developing this advanced…

STU Framatome

Framatome and STU To Support Nuclear E&T in Slovakia

Framatome and STU To Support Nuclear E&T in Slovakia Last week, Framatome (ENS Corporate Member) announced the signing of a Memorandum of Understanding (MoU) with the Slovak University of Technology (STU) in Bratislava to explore and pursue collaborative opportunities in education and training in the field of nuclear energy. The Memorandum of Understanding was signed…

Ansaldo Nucleare Supporting LTO at Cernavoda NPP

Ansaldo Nucleare Supporting LTO at Cernavoda NPP Last week, Ansaldo Nucleare (ENS Corporate Member), the Italian insurance-financial group SACE, and the Romanian nuclear energy company Societatea Nationala Nuclearelectrica S.A. (SNN) signed a Memorandum of Understanding to secure a financing line of up to €2bn to carry out work to extend the life of Unit 1…